Quality of Life, Anxiety and Fatigue Level of Parkison's Patients With Color Therapy

NCT06154772 | Completed

• 1 other identifier: 27/09/2023
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study was to investigate the effect of color therapy on quality of life, anxiety and fatigue levels in patients with Parkinson's disease.

Conditions

Parkinson

Keywords

Color therapy

Outcome Measures

Primary Outcomes (3)

• Quality of Life Scale (SF36)

  It was developed to measure the quality of life in people with physical diseases. It is measured in 8 dimensions and 36 items: physical function, physical role difficulty, emotional role difficulty, viability, mental health, social functionality, pain, and general health perception.

  At the end of Color Therapy (therapy 9 times in total in 3 months)

• Beck Anxiety Inventory (BAI)

  It consists of 21 questions and a minimum score of 0 and a maximum score of 3 is obtained from each question. As a result of the answers to all questions, all answers are summed up and a total score is obtained. In the evaluation phase, the presence and level of depression is interpreted in line with the meanings expressed by the score ranges. In the evaluation, 0-9 point range defines the presence of minimal depressive symptoms, 10-16 point range defines the presence of mild depressive symptoms, 17-29 point range defines the presence of moderate depressive symptoms and 30-63 point range defines the presence of severe depressive symptoms. A score of 17 and above indicates a level of depression that may require treatment.

  At the end of Color Therapy (therapy 9 times in total in 3 months)

• Parkinson's Fatigue Scale (PYO-16)

  It consists of 16 items, with 5 responses for each item (1=strongly disagree, 5=strongly agree). The result evaluation can be done in two different ways. The total value is calculated as the average of the response to all items (value range 1-5). Scores above the average "3.3" are considered tired. In the other rating option, 0 (actual response 1-3) and 1 (actual response 4-5) are scored, with a total value between 0-16. A total of 8 points and above is considered tired. In both methods, a higher value indicates a higher level of fatigue.

  At the end of Color Therapy (therapy 9 times in total in 3 months)

Study Arms (2)

Color Therapy

EXPERIMENTAL

Balancing body chakras with colors. Colors are applied to the body's chakras for 10-15 minutes.

Other: Color Therapy

Control Group

NO INTERVENTION

Routine maintenance will be applied

Interventions

Color Therapy OTHER

Color therapy will be applied to the body chakras for 10-15 minutes with colored fabrics, color therapy with water and colored light lamp.

Color Therapy

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Having been diagnosed with Parkinson's disease for at least 6 months,
• Those who have not taken sleeping pills or sedative drugs,
• Not having undergone brain stimulation surgery,
• Do not have a physical illness or cognitive disability that would prevent them from understanding the education provided, and do not have a diagnosis of a psychiatric disease,
• According to the Parkinson's Fatigue Scale, the scale score is \>8
• The patient or someone living in the same house with the patient is literate,
• Patients have no vision problems.

You may not qualify if:

• Parkinson patients who did not agree to participate in the research

Sponsors & Collaborators

• Ataturk University: lead

Study Sites (1)

Firat University

Elâzığ, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Color Therapy

Intervention Hierarchy (Ancestors)

Sensory Art Therapies; Complementary Therapies; Therapeutics; Phototherapy; Psychotherapy; Behavioral Disciplines and Activities

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Single
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: This study is an experimental study with pre-test and post-test control groups

Study Record Dates

• First Submitted: November 24, 2023
• First Posted: December 4, 2023
• Study Start: November 1, 2023
• Primary Completion: April 27, 2024
• Study Completion: June 30, 2024
• Last Updated: November 25, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)